Traders sold shares of Humana Inc. (NYSE:HUM) on strength during trading on Friday after Royal Bank Of Canada lowered their price target on the stock from $222.00 to $217.00. $50.62 million flowed into the stock on the tick-up and $92.80 million flowed out of the stock on the tick-down, for a money net flow of $42.18 million out of the stock. Of all companies tracked, Humana had the 22nd highest net out-flow for the day. Humana traded up $1.34 for the day and closed at $170.82

HUM has been the topic of a number of other reports. Zacks Investment Research cut Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, September 21st. JPMorgan Chase & Co. cut Humana from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $196.00 to $150.00 in a research note on Friday, July 8th. Evercore ISI initiated coverage on Humana in a research note on Thursday, September 22nd. They set a “buy” rating and a $200.00 price target on the stock. Argus restated a “hold” rating on shares of Humana in a research note on Tuesday, August 23rd. Finally, Wolfe Research upgraded Humana to an “outperform” rating and set a $192.00 price target on the stock in a research note on Thursday, July 21st. Seven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $200.50.

Several institutional investors have recently added to or reduced their stakes in HUM. Prudential PLC raised its position in Humana by 3.0% in the first quarter. Prudential PLC now owns 8,866 shares of the insurance provider’s stock worth $1,622,000 after buying an additional 259 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Humana by 2.3% in the first quarter. Geode Capital Management LLC now owns 1,166,562 shares of the insurance provider’s stock worth $212,975,000 after buying an additional 25,947 shares during the last quarter. Loomis Sayles & Co. L P increased its stake in shares of Humana by 52.6% in the first quarter. Loomis Sayles & Co. L P now owns 300,004 shares of the insurance provider’s stock worth $54,886,000 after buying an additional 103,370 shares during the last quarter. Nicholas Investment Partners LP increased its stake in shares of Humana by 45.1% in the first quarter. Nicholas Investment Partners LP now owns 6,983 shares of the insurance provider’s stock worth $1,278,000 after buying an additional 2,170 shares during the last quarter. Finally, Pictet Asset Management Ltd. increased its stake in shares of Humana by 2.2% in the first quarter. Pictet Asset Management Ltd. now owns 169,409 shares of the insurance provider’s stock worth $29,981,000 after buying an additional 3,610 shares during the last quarter. 93.24% of the stock is currently owned by hedge funds and other institutional investors.

The stock has a market capitalization of $25.46 billion, a PE ratio of 26.24 and a beta of 0.90. The company’s 50 day moving average price is $176.12 and its 200 day moving average price is $175.83.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. The company earned $14 billion during the quarter, compared to analyst estimates of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. The business’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.67 EPS. Analysts forecast that Humana Inc. will post $9.24 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s dividend payout ratio is currently 18.18%.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.